TABLE 2.
Participant characteristics (n = 62)
| N (%) | M± SD | |
|---|---|---|
| Demographic characteristics | ||
| Age at time of testing (years) | 10.8 ± 2.9 | |
| Sex | ||
| Male | 31 (50) | |
| Female | 31 (50) | |
| Race/ethnicity | ||
| Latino | 62 (100) | |
| Treatment characteristics | ||
| Acute lymphoblastic leukemia | 57(91.9) | |
| Lymphoblastic non-Hodgkin lymphoma | 5(8.1) | |
| Age at diagnosis (years) | 4.5 ± 2.7 | |
| Time posttreatment (months) | 44.7 ± 30.4 | |
| Cumulative dose of intrathecal methotrexate (mg) | 231.5 ± 48.2 | |
| Cumulative dose of intrathecal cytarabine (mg) | 65.0 ± 26.43 | |
| Received high-dose IV methotrexate (>1 g) | 9 (14.5) | |
| Social characteristics | ||
| Primary home language | ||
| English | 27 (43.5) | |
| Spanish | 35 (56.5) | |
| Hollingshead SES category | ||
| Category I | 1(1.6) | |
| Category II | 14 (22.6) | |
| Category III | 5(8.1) | |
| Category IV | 14 (22.6) | |
| Category V | 28 (45.2) | |
| Household size | 5.3 ± 1.5 | |
| Estimated household income (US dollars) | $46,519 ± $14,653 | |
| Insurance type | ||
| Public | 53 (85.5) | |
| Private | 9 (14.5) | |